Targeted Strategies for Today's Evolving Markets

MissionIR Blog

MissionIRNewsBreaks – Organigram Holdings Inc. (NASDAQ: OGI) (TSX: OGI) Receives Health Canada Approval for Licensing of 16 Additional Cultivation Rooms Under Cannabis Regulations

Organigram Holdings (NASDAQ: OGI) (TSX: OGI), the parent company of Organigram Inc. (the “company” or “Organigram”), a leading licensed producer of cannabis, today announced the company’s receipt of Health Canada’s approval for the licensing of 16 additional cultivation rooms under the Cannabis Regulations. According to the update, the expanded license was effective as of December 12, 2019, and the new cultivation rooms represent approximately 13,000 kg/yr1 of increased target cultivation capacity. “This is a dynamic time for Organigram and the industry as a whole. Cannabis 2.0 – the legalization of adult use recreational cannabis edibles, vape products, extracts and topicals – is a new era for cannabis here at home and around the world,” Organigram CEO Greg Engel said in the news release. “Our physical expansion reflects our ambitious response to this new opportunity as well as our ongoing commitment to anticipating and meeting the demands of Canadian cannabis consumers for new and innovative cannabis experiences.”

To view the full press release, visit http://ibn.fm/PE1mj

About Organigram Holdings Inc.

Organigram Holdings Inc. is a NASDAQ Global Select and TSX listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of cannabis and cannabis-derived products in Canada. Organigram is focused on producing high-quality, indoor-grown cannabis for patients and adult recreational consumers in Canada, as well as developing international business partnerships to extend the Company’s global footprint. Organigram has also developed a portfolio of legal adult use recreational cannabis brands including The Edison Cannabis Company, Ankr Organics and Trailblazer. Organigram’s primary facility is located in Moncton, New Brunswick and the Company is regulated by the Cannabis Act and the Cannabis Regulations (Canada). For more information, visit the company’s website at www.Organigram.ca.

About MissionIRNewsBreaks

MissionIRNewsBreaks provide a rapid summary of corporate news that catch the attention of MissionIR. MissionIRNewsBreaks are created by our Team of professional journalists that keep a constant eye on the markets, these posts are designed to inform you on the latest happenings of our clients and other publicly traded companies on our radar. From earnings, acquisitions and agreements to conference attendance and clinical study results, our news breaks keep you up-to-date with the day’s top movers. MissionIR is primarily focused on strategic communications. We have executed countless communications programs to address the needs of companies ranging from start-ups to established industry leaders, gaining valuable experience and the expertise necessary to determine the most effective strategy for any given situation.

MissionIR (MIR)
Atlanta, Georgia
www.MissionIR.com
404.941.8975 Office
[email protected]

Please see full terms of use and disclaimers on the Mission Investor Relations website applicable to all content provided by MIR, wherever published or re-published: http://www.missionir.com/disclaimer.html

This entry was posted in MissionIRNewsBreaks, Organigram Holdings Inc. OGI. Bookmark the permalink.

Comments are closed.